BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

786 related articles for article (PubMed ID: 28671918)

  • 1. A Comparison of Distortion Product Otoacoustic Emission Properties in Ménière's Disease Patients and Normal-Hearing Participants.
    Drexl M; Krause E; Gürkov R
    Ear Hear; 2018; 39(1):42-47. PubMed ID: 28671918
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distortion-product otoacoustic emissions and cochlear microphonics: relationships in patients with and without endolymphatic hydrops.
    Fetterman BL
    Laryngoscope; 2001 Jun; 111(6):946-54. PubMed ID: 11404602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship Between Audio-Vestibular Functional Tests and Inner Ear MRI in Meniere's Disease.
    Quatre R; Attyé A; Karkas A; Job A; Dumas G; Schmerber S
    Ear Hear; 2019; 40(1):168-176. PubMed ID: 29698363
    [TBL] [Abstract][Full Text] [Related]  

  • 4. On the differential diagnosis of Ménière's disease using low-frequency acoustic biasing of the 2f1-f2 DPOAE.
    Brown DJ; Gibson WP
    Hear Res; 2011 Dec; 282(1-2):119-27. PubMed ID: 21944944
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distortion-product otoacoustic emissions and glycerol testing in endolymphatic hydrops.
    Magliulo G; Cianfrone G; Triches L; Altissimi G; D'Amico R
    Laryngoscope; 2001 Jan; 111(1):102-9. PubMed ID: 11192876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Changes in otoacoustic emission during the glycerol test in the ears of patients with Meniere's disease].
    Sakashita T; Kubo T; Kyunai K; Ueno K; Hikawa C; Shibata T; Yamane H; Kusuki M; Wada T; Uyama T
    Nihon Jibiinkoka Gakkai Kaiho; 2001 Jun; 104(6):682-93. PubMed ID: 11494522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormal fast fluctuations of electrocochleography and otoacoustic emissions in Menière's disease.
    Gerenton G; Giraudet F; Djennaoui I; Pavier Y; Gilain L; Mom T; Avan P
    Hear Res; 2015 Sep; 327():199-208. PubMed ID: 26232527
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting sensitivity of distortion-product otoacoustic emissions to ototoxic hearing loss.
    Reavis KM; Phillips DS; Fausti SA; Gordon JS; Helt WJ; Wilmington D; Bratt GW; Konrad-Martin D
    Ear Hear; 2008 Dec; 29(6):875-93. PubMed ID: 18753950
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of glycerol test in Meniere's disease with pure tone audiometry and distortion product otoacoustic emission].
    Jabłonka A; Pośpiech L; Orendorz-Fraczkowska K
    Otolaryngol Pol; 2003; 57(5):731-7. PubMed ID: 14994621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in distortion product otoacoustic emissions from ears with Menière's disease.
    Kusuki M; Sakashita T; Kubo T; Kyunai K; Ueno K; Hikawa C; Wada T; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():78-89. PubMed ID: 9879406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in input/output function of distortion product otoacoustic emissions during the glycerol test in Ménière's disease.
    Sakashita T; Shibata T; Yamane H; Hikawa C
    Acta Otolaryngol Suppl; 2004 Oct; (554):26-9. PubMed ID: 15513506
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of hearing loss using 2f2-f1 and 2f1-f2 distortion-product otoacoustic emissions.
    Fitzgerald TS; Prieve BA
    J Speech Lang Hear Res; 2005 Oct; 48(5):1165-86. PubMed ID: 16411804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Diagnosis of endolymphatic hydrops using low frequency modulated distortion product otoacoustic emissions].
    Hirschfelder A; Gossow-Müller-Hohenstein E; Hensel J; Scholz G; Mrowinski D
    HNO; 2005 Jul; 53(7):612-7. PubMed ID: 15565422
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Diagnosis of endolymphatic hydrops with low tone masked otoacoustic emissions].
    Nubel K; Kabudwand E; Scholz G; Mrowinski D
    Laryngorhinootologie; 1995 Nov; 74(11):651-6. PubMed ID: 8561815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of change in growth function of distortion product otoacoustic emissions in Menière's disease.
    Sakashita T; Kubo T; Kusuki M; Kyunai K; Ueno K; Hikawa C; Wada T; Shibata T; Nakai Y
    Acta Otolaryngol Suppl; 1998; 538():70-7. PubMed ID: 9879405
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization of endolymphatic hydrops and correlation with audio-vestibular functional testing in patients with definite Meniere's disease.
    Seo YJ; Kim J; Choi JY; Lee WS
    Auris Nasus Larynx; 2013 Apr; 40(2):167-72. PubMed ID: 22867525
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pure-tone threshold estimation from extrapolated distortion product otoacoustic emission I/O-functions in normal and cochlear hearing loss ears.
    Boege P; Janssen T
    J Acoust Soc Am; 2002 Apr; 111(4):1810-8. PubMed ID: 12002865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of inner ear hearing loss on delayed otoacoustic emissions (TEOAE) and distortion products (DPOAE)].
    Hoth S
    Laryngorhinootologie; 1996 Dec; 75(12):709-18. PubMed ID: 9081275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early diagnosis of endolymphatic hydrops with distortion. Product otoacoustic emissions.
    Magliulo G; Cianfrone G; Di Cello P; Tersigni A
    An Otorrinolaringol Ibero Am; 2004; 31(2):173-89. PubMed ID: 15185614
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploring Optimal Stimulus Frequency Ratio for Measurement of the Quadratic f2-f1 Distortion Product Otoacoustic Emission in Humans.
    Baiduc RR; Dhar S
    J Speech Lang Hear Res; 2018 Jul; 61(7):1794-1806. PubMed ID: 29946695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.